natur
review
microbiolog
launch
octob
issu
mark
offici
anniversari
anniversari
one
come
mixtur
emot
amaz
new
member
team
journal
around
long
relief
old
guard
mileston
inde
editori
reach
compar
unscath
anniversari
afford
one
chanc
take
trip
memori
lane
editori
mark
year
journal
variou
path
could
take
discuss
thought
would
insight
select
key
articl
first
three
issu
assess
progress
made
area
sinc
octob
issu
obviou
choic
discuss
opinion
articl
christoph
walsh
new
antibiot
come
among
issu
discuss
walsh
highlight
innov
gap
antimicrobi
develop
linezolid
first
repres
major
new
structur
class
antibiot
oxazolidinon
approv
almost
year
year
evid
innov
gap
still
exist
repres
four
new
class
antibiot
lipopeptid
glycylcyclin
pleuromutilin
diarylquinolin
reach
market
period
despit
increas
number
initi
tackl
problem
recent
year
involv
key
stakehold
research
academia
industri
antibiot
resist
remain
one
press
problem
health
care
today
discuss
previou
editori
year
unit
kingdom
grow
polit
interest
antibioticresist
crisi
encourag
fact
remain
littl
progress
seem
made
sinc
walsh
articl
alarm
increas
multidrugresist
gramneg
bacteria
particular
give
real
caus
concern
mani
respect
comment
warn
risk
return
preantibiot
era
branch
medicin
avail
treatment
option
declin
past
decad
infecti
diseas
certainli
one
novemb
issu
review
mycobacterium
tuberculosi
persist
dougla
young
colleagu
anoth
articl
still
reson
today
although
global
mortal
tuberculosi
tb
declin
past
year
reduct
may
enough
meet
target
set
millennium
develop
goal
million
infect
million
death
tb
tuberculosi
highli
success
pathogen
establish
asymptomat
latent
infect
later
becom
reactiv
infect
individu
articl
young
colleagu
cover
mani
gener
issu
associ
tuberculosi
latenc
includ
immun
respons
persist
infect
implic
latenc
vaccin
develop
unfortun
new
tb
vaccin
seem
closer
year
ago
recent
failur
booster
vaccin
major
setback
tb
keyston
meet
whistler
canada
year
clear
gener
consensu
field
urgent
need
reevalu
knowledg
immun
respons
pathogen
order
achiev
better
understand
immun
correl
protect
come
close
achiev
howev
inform
potenti
new
strategi
tb
vaccin
drug
develop
requir
better
anim
model
said
progress
made
understand
biolog
organ
anticip
system
biolog
studi
major
role
improv
understand
inner
work
tuberculosi
next
year
moreov
earli
work
tuberculosi
persist
cell
one
main
driver
use
microfluid
studi
microbi
singlecel
heterogen
field
gone
strength
strength
past
decad
persist
gener
though
difficult
studi
although
use
microfluid
brought
advanc
question
answer
abound
regard
main
physiolog
featur
persist
best
approach
elimin
featur
recent
viewpoint
articl
decemb
publish
first
review
sever
acut
respiratori
syndrom
coronaviru
sarscov
first
sarscov
infect
report
late
pandem
escal
februari
subsequ
day
case
report
countri
death
total
review
stadler
et
al
reflect
earli
research
phylogeni
viru
replic
potenti
therapeut
intervent
subsequ
year
fund
boost
paid
dividend
coronaviru
biologist
old
new
understand
molecular
biolog
immunopathogenesi
viru
famili
greatli
improv
search
sourc
outbreak
eventu
led
identif
bat
like
sourc
highlight
import
anim
viral
reservoir
moreov
gener
increas
interest
emerg
viral
diseas
past
decad
although
initi
respons
pandem
prais
ident
viru
genom
sequenc
rapidli
obtain
sar
first
pandem
twentyfirst
centuri
dust
settl
clear
need
much
greater
emphasi
pandem
prepared
diseas
surveil
need
reemerg
influenza
viru
outbreak
along
need
open
commun
countri
area
prove
difficult
ongo
middl
east
respiratori
syndrom
cov
merscov
outbreak
septemb
report
began
emerg
infect
novel
cov
subsequ
identifi
merscov
date
transmiss
cluster
report
least
eight
differ
countri
begin
septemb
notifi
laboratoryconfirm
infect
includ
death
reflect
reassess
articl
archiv
could
give
impress
microbiolog
made
littl
progress
cours
past
year
antibiot
pipelin
still
broken
persist
still
mysteri
anoth
seriou
cov
outbreak
ongo
cours
impress
could
nt
truth
realiti
past
decad
microbiolog
research
gone
strength
strength
vibrant
relev
ever
technolog
advanc
advent
nextgener
wholegenom
sequenc
brought
genuin
amaz
insight
microbi
world
around
within
us
realiz
first
issu
natur
review
microbiolog
publish
intent
purpos
thing
microbiom
type
vi
secret
system
cyclic
digmp
crispr
mention
anticrispr
give
sens
chang
occur
past
year
continu
exist
journal
cours
possibl
valu
contribut
respect
commun
author
refere
reader
thank
look
forward
microbi
adventur
ahead
next
year
